Speculation Grows That Teva Close to Giant M&A Deal

Share price rallied last week after a Cowen analyst suggested Teva would buy the U.S. company Mylan.

comments Print
The promise by Teva Pharmaceuticals CEO Erez Vigodman that 2015 would be a busy one for the world’s biggest maker of generic drugs may be coming true: Teva’s share price jumped 6.3% on Wednesday and Thursday...